Arcturus Therapeutics Holdings Inc. (ARCT) vs Capricor Therapeutics, Inc. (CAPR)
A side-by-side comparison of Arcturus Therapeutics Holdings Inc. and Capricor Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARCT
Arcturus Therapeutics Holdings Inc.
$13.33HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
CAPR
Capricor Therapeutics, Inc.
$7.62HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Total return — ARCT vs CAPR
growth of $100 · dividends reinvested · last 10yARCT -19.5% (-2.1%/yr)CAPR -76.9% (-13.6%/yr)ARCT compounded faster over this window
ARCT CAPR
ARCT vs CAPR: by the numbers
- •CAPR is the larger company ($438M vs $379M market cap).
- •Both run net losses; CAPR's is the smaller (0.00% vs -391.90% net margin).
Metrics side by side
Valuation
| Metric | ARCT | CAPR |
|---|---|---|
| P/S ratio | 15.92 | N/A |
| P/B ratio | 2.21 | 1.78 |
| EV / EBITDA | N/A | 0.44 |
Profitability
| Metric | ARCT | CAPR |
|---|---|---|
| Gross margin | 95.50% | 0.00% |
| Operating margin | -111.51% | 0.00% |
| Net margin | -391.90% | 0.00% |
| ROE | -54.29% | -52.56% |
| ROIC | -54.07% | -40.25% |
Growth (annualized)
| Metric | ARCT | CAPR |
|---|---|---|
| Revenue CAGR (5Y) | 22.30% | N/A |
| Total return CAGR (5Y) | -18.73% | 15.17% |
Frequently asked
- How have ARCT and CAPR total returns compared?
- Over the past 10 years, ARCT delivered -2.54% and CAPR delivered -13.84% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Arcturus Therapeutics ROECapricor Therapeutics ROEArcturus Therapeutics operating marginCapricor Therapeutics operating marginArcturus Therapeutics revenue growthCapricor Therapeutics revenue growthArcturus Therapeutics free cash flowCapricor Therapeutics free cash flow
Arcturus Therapeutics & Capricor Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.